Equities analysts expect Aetna Inc (NYSE:AET) to post $15.20 billion in sales for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Aetna’s earnings, with the highest sales estimate coming in at $15.61 billion and the lowest estimate coming in at $14.85 billion. Aetna reported sales of $15.17 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 0.2%. The firm is scheduled to announce its next earnings report before the market opens on Tuesday, May 1st.
According to Zacks, analysts expect that Aetna will report full year sales of $15.20 billion for the current year, with estimates ranging from $59.16 billion to $63.44 billion. For the next financial year, analysts expect that the firm will post sales of $64.84 billion per share, with estimates ranging from $61.76 billion to $67.69 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research analysts that cover Aetna.
Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.07. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The business had revenue of $14.74 billion during the quarter, compared to analysts’ expectations of $14.79 billion. During the same period in the previous year, the firm earned $0.08 earnings per share. The firm’s quarterly revenue was down 6.2% compared to the same quarter last year.
A number of research analysts have issued reports on AET shares. Piper Jaffray reissued a “buy” rating and issued a $212.00 target price on shares of Aetna in a research note on Tuesday, January 30th. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Credit Suisse Group boosted their target price on Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a research note on Wednesday, January 31st. Cowen reissued a “buy” rating and issued a $212.00 target price on shares of Aetna in a research note on Tuesday, January 30th. Finally, Citigroup cut Aetna from a “buy” rating to a “neutral” rating and boosted their target price for the company from $187.89 to $212.00 in a research note on Wednesday, January 31st. Nine research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $189.50.
Several institutional investors have recently modified their holdings of the company. Employees Retirement System of Texas raised its holdings in Aetna by 23.3% during the fourth quarter. Employees Retirement System of Texas now owns 79,381 shares of the company’s stock worth $14,320,000 after acquiring an additional 15,000 shares in the last quarter. Water Island Capital LLC raised its holdings in Aetna by 224.6% during the fourth quarter. Water Island Capital LLC now owns 150,787 shares of the company’s stock worth $27,200,000 after acquiring an additional 104,337 shares in the last quarter. Farallon Capital Management LLC bought a new stake in Aetna during the fourth quarter worth about $940,734,000. Gotham Asset Management LLC raised its holdings in Aetna by 5.7% during the fourth quarter. Gotham Asset Management LLC now owns 46,880 shares of the company’s stock worth $8,457,000 after acquiring an additional 2,536 shares in the last quarter. Finally, Leucadia National Corp bought a new stake in Aetna during the fourth quarter worth about $29,404,000. Institutional investors own 87.25% of the company’s stock.
Shares of Aetna stock opened at $173.28 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.65 and a debt-to-equity ratio of 0.52. Aetna has a 12 month low of $127.86 and a 12 month high of $194.40. The firm has a market cap of $56,845.49, a P/E ratio of 17.57, a P/E/G ratio of 1.41 and a beta of 0.67.
The company also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Thursday, April 12th will be issued a $0.50 dividend. The ex-dividend date is Wednesday, April 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.15%. Aetna’s dividend payout ratio (DPR) is 20.28%.
TRADEMARK VIOLATION WARNING: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/04/13/aetna-inc-aet-expected-to-post-quarterly-sales-of-15-20-billion.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Get a free copy of the Zacks research report on Aetna (AET)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.